Envista Holdings (NVST) Stock Overview
Develops, manufactures, markets, and sells dental products in the United States, China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for NVST from our risk checks.
NVST Community Fair Values
Create NarrativeSee what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Envista Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$22.94 |
| 52 Week High | US$30.42 |
| 52 Week Low | US$17.91 |
| Beta | 0.93 |
| 1 Month Change | -12.88% |
| 3 Month Change | -19.31% |
| 1 Year Change | 22.48% |
| 3 Year Change | -30.17% |
| 5 Year Change | -46.63% |
| Change since IPO | -17.92% |
Recent News & Updates
Narrative Update • Jun 01
NVST: Mixed Research And Buybacks Will Shape Returns If Execution Improves
Envista Holdings' analyst fair value estimate has shifted from about $20.01 to roughly $22.09. Analysts attribute the change to updated assumptions around revenue growth, margins, discount rate, and future P/E, alongside mixed but active recent coverage on the stock.Seeking Alpha • May 07
Envista: Spotlight On Q1 Outperformance And New Growth Drivers
Summary My existing 'buy' rating for Envista is left unchanged following my evaluation of its results and outlook. NVST's 1Q2026 earnings beat consensus by 15%, thanks to a defensive dental market and the company's own cost reduction efforts. The company's high-teens EPS growth guidance for the full year is well-supported by new product launches and synergies relating to its latest M&A. Read the full article on Seeking Alpha
Narrative Update • May 05
NVST: 2026 Execution And Buybacks Will Drive Repriced Earnings Outlook
Envista Holdings' analyst fair value estimate has edged up by about $0.15 per share as analysts factor in slightly lower discount rates and modestly higher future P/E expectations, following a series of recent price target adjustments and rating changes across the Street. Analyst Commentary Recent Street research on Envista Holdings shows a mix of optimism and caution, with several price target revisions and at least one rating upgrade contributing to a modest uplift in analyst fair value estimates.Recent updates
Narrative Update • Jun 01
NVST: Mixed Research And Buybacks Will Shape Returns If Execution Improves
Envista Holdings' analyst fair value estimate has shifted from about $20.01 to roughly $22.09. Analysts attribute the change to updated assumptions around revenue growth, margins, discount rate, and future P/E, alongside mixed but active recent coverage on the stock.Seeking Alpha • May 07
Envista: Spotlight On Q1 Outperformance And New Growth Drivers
Summary My existing 'buy' rating for Envista is left unchanged following my evaluation of its results and outlook. NVST's 1Q2026 earnings beat consensus by 15%, thanks to a defensive dental market and the company's own cost reduction efforts. The company's high-teens EPS growth guidance for the full year is well-supported by new product launches and synergies relating to its latest M&A. Read the full article on Seeking AlphaNarrative Update • May 05
NVST: 2026 Execution And Buybacks Will Drive Repriced Earnings Outlook
Envista Holdings' analyst fair value estimate has edged up by about $0.15 per share as analysts factor in slightly lower discount rates and modestly higher future P/E expectations, following a series of recent price target adjustments and rating changes across the Street. Analyst Commentary Recent Street research on Envista Holdings shows a mix of optimism and caution, with several price target revisions and at least one rating upgrade contributing to a modest uplift in analyst fair value estimates.Narrative Update • Apr 21
NVST: Mixed Sentiment On 2026 Execution And Buybacks Will Shape Repriced Earnings
The analyst price target for Envista Holdings has been trimmed slightly, as analysts factor in a marginally higher discount rate, slightly softer revenue growth assumptions, and a modestly lower future P/E multiple. The new target still reflects recent mixed Street research that includes both target increases and a $2 cut from Evercore ISI, alongside fresh neutral initiation coverage.Narrative Update • Apr 06
NVST: Elevated Multiple Will Pressure Future Returns If Execution Falters
Envista Holdings' updated analyst price target edges slightly higher, with recent $1 to $6 target boosts and several upgrades. These changes point to analysts expecting modestly stronger growth, improving execution and a small reset in valuation assumptions.Narrative Update • Mar 23
NVST: Execution On 2026 Guidance And Buybacks Will Support Repriced Earnings
Envista Holdings' updated analyst price target has edged higher, with a modest fair value increase to $28.67. This change is supported by analysts who cite recent target hikes across multiple firms and a reassessment of long term profitability and P/E assumptions.Narrative Update • Mar 09
NVST: Higher Multiple Expectations Will Constrain Future Upside If Profitability Lags
Envista Holdings' analyst fair value estimate has moved from $18.00 to about $20.03. Analysts point to updated expectations for revenue growth, profitability, and a higher future P/E multiple as key drivers behind the new price targets and recent upgrades.Narrative Update • Feb 23
NVST: Execution And 2026 Guidance Will Test Repriced Earnings Expectations
Envista Holdings' analyst price target has increased to $28.46 from $22.15, as analysts cite updated assumptions around revenue growth, profit margins and future P/E multiples following a series of recent target hikes and upgrades across the Street. Analyst Commentary Recent research activity around Envista centers on a cluster of price target hikes and several upgrades, with analysts updating their models for revenue growth, margin potential and P/E multiples.
Narrative Update • Feb 08
NVST: Improved Execution And Higher Future P/E Could Drive Stronger Earnings Power
Envista Holdings' analyst fair value estimate has shifted from $28.00 to $35.00, as analysts broadly raise price targets and upgrade ratings, citing improved growth execution and updated assumptions for revenue, margins, and future P/E expectations. Analyst Commentary Across recent research updates, bullish analysts have moved in the same direction, lifting price targets and, in several cases, upgrading their ratings on Envista Holdings.Narrative Update • Jan 24
NVST: Margin Expansion And Buybacks Will Support Stronger Future Earnings Power
Analysts have nudged their fair value estimate for Envista Holdings up from $27.00 to $28.00, citing recent research that points to steady revenue expectations, slightly higher projected profit margins, and a modestly lower assumed future P/E multiple following the company’s latest earnings and updated EPS and sales outlook. Analyst Commentary Bullish analysts appear encouraged by Envista Holdings’ latest earnings update and guidance, particularly where it ties back to consistent execution on revenue and profitability targets.Narrative Update • Jan 09
NVST: Narrowed FY25 Outlook Will Limit Upside After Recent EPS Miss
Narrative update Analysts have raised their price target fair value for Envista from $17.00 to $18.00, citing recent quarterly results that were framed positively by management, along with the narrowed FY25 EPS and sales growth outlook as key inputs into updated growth, margin, discount rate, and future P/E assumptions. Analyst Commentary Street research around Envista’s latest quarter has been mixed, even with management describing Q3 as a strong period.Analysis Article • Jan 09
Improved Revenues Required Before Envista Holdings Corporation (NYSE:NVST) Shares Find Their Feet
With a price-to-sales (or "P/S") ratio of 1.5x Envista Holdings Corporation ( NYSE:NVST ) may be sending bullish...Narrative Update • Dec 25
NVST: Margin Expansion And Share Repurchases Will Drive Stronger Future Earnings Power
Analysts have raised their fair value estimate for Envista Holdings by $2 to $27 per share, citing slightly stronger expected revenue growth, a sharp improvement in projected profit margins, and a more balanced long term earnings multiple despite modestly higher discount rate assumptions. Analyst Commentary Bullish analysts highlighted that Envista's latest quarterly results, while slightly below consensus on revenue and EPS, demonstrated underlying operational strength.Narrative Update • Dec 11
NVST: Tighter EPS Guidance And Profitability Improvements Will Shape 2025 Outlook
Analysts have modestly raised their price target on Envista Holdings to approximately $22.15 per share from $22.00, citing the company’s stronger than expected core performance, improving profitability, and tightened FY25 EPS and sales growth guidance as support for a slightly higher fair value and future earnings multiple. Analyst Commentary Analysts view Envista’s latest quarter and updated outlook as a mixed but generally constructive signal, with operational execution trending ahead of expectations even as headline results modestly lag consensus.Analysis Article • Dec 03
Is Envista Holdings (NYSE:NVST) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Narrative Update • Nov 26
NVST: Stable Margins And Tighter Guidance Will Shape 2025 Performance
Analysts have maintained their price target for Envista Holdings at $22.00 per share. Recent updates balance modestly lower revenue growth projections with improved profit margins and a better profit outlook, which supports stable valuation expectations.Analysis Article • Nov 06
Shareholders Will Be Pleased With The Quality of Envista Holdings' (NYSE:NVST) Earnings
The subdued stock price reaction suggests that Envista Holdings Corporation's ( NYSE:NVST ) strong earnings didn't...Narrative Update • Nov 02
NVST: Profit Margin Expansion And Core Momentum Will Offset Mixed Near-Term Performance
Analysts have raised their price target for Envista Holdings from $21.42 to $22.00 per share. They cite increased profit margin estimates, an improved revenue growth outlook, and a slightly higher fair value driven by recent performance and updated FY25 guidance.Analysis Article • Aug 03
Earnings Beat: Envista Holdings Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
A week ago, Envista Holdings Corporation ( NYSE:NVST ) came out with a strong set of second-quarter numbers that could...Analysis Article • Aug 01
Is It Too Late To Consider Buying Envista Holdings Corporation (NYSE:NVST)?
While Envista Holdings Corporation ( NYSE:NVST ) might not have the largest market cap around , it led the NYSE gainers...New Narrative • May 26
Expanding Digital Dentistry And Aging Demographics Will Drive Industry Transformation
Expansion in digital dentistry and premium product innovation positions Envista for higher margins and revenue diversification amid industry shifts toward advanced, aesthetic solutions.Analysis Article • May 21
We Think Envista Holdings (NYSE:NVST) Can Stay On Top Of Its Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysis Article • May 03
Is There An Opportunity With Envista Holdings Corporation's (NYSE:NVST) 39% Undervaluation?
Key Insights Envista Holdings' estimated fair value is US$27.75 based on 2 Stage Free Cash Flow to Equity Envista...Seeking Alpha • Apr 28
Envista Holdings: A Mixed Picture
Summary Today, we take a deeper look at Envista Holdings Corporation, a dental supply and equipment company. The stock appears to be trying to bottom after a recent decline and despite negative analyst firm opinion on the shares. The company has recently instituted a significant stock buyback program and from a historical perspective, the shares are cheap on a price to sales ratio basis. Envista also threw out a considerable amount of free cash flow in FY2024, and a recently completed restructuring should yield additional annual savings. An analysis around Envista Holdings Corporation follows in the paragraphs below. Read the full article on Seeking AlphaAnalysis Article • Apr 15
What Is Envista Holdings Corporation's (NYSE:NVST) Share Price Doing?
Envista Holdings Corporation ( NYSE:NVST ), is not the largest company out there, but it received a lot of attention...Analysis Article • Feb 20
There Is A Reason Envista Holdings Corporation's (NYSE:NVST) Price Is Undemanding
Envista Holdings Corporation's ( NYSE:NVST ) price-to-sales (or "P/S") ratio of 1.5x might make it look like a strong...Analysis Article • Feb 02
We Think Envista Holdings (NYSE:NVST) Is Taking Some Risk With Its Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Seeking Alpha • Jan 22
Envista Is A Margin Improvement Story (Rating Upgrade)
Summary I upgrade Envista stock to a buy due to its potential for increased profitability in 2025. The Implants segment, NVST's largest business unit, is expected to witness positive sales expansion in the coming quarters by capitalizing on its brand strength in a market with favorable recovery prospects. The clear aligner business targets to achieve positive operating profit for the current year, considering the appointment of new leadership and the company management's recent comments. Read the full article on Seeking AlphaAnalysis Article • Jan 15
A Look At The Fair Value Of Envista Holdings Corporation (NYSE:NVST)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Envista Holdings fair value estimate is US$20.86 With US$18.85...Analysis Article • Dec 28
Is Envista Holdings Corporation (NYSE:NVST) Potentially Undervalued?
While Envista Holdings Corporation ( NYSE:NVST ) might not have the largest market cap around , it saw significant...Analysis Article • Nov 22
Envista Holdings Corporation's (NYSE:NVST) Prospects Need A Boost To Lift Shares
Envista Holdings Corporation's ( NYSE:NVST ) price-to-sales (or "P/S") ratio of 1.5x might make it look like a buy...Analysis Article • Oct 25
We Think Envista Holdings (NYSE:NVST) Is Taking Some Risk With Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analysis Article • Oct 07
Envista Holdings Corporation's (NYSE:NVST) Intrinsic Value Is Potentially 51% Above Its Share Price
Key Insights The projected fair value for Envista Holdings is US$28.44 based on 2 Stage Free Cash Flow to Equity...Seeking Alpha • Aug 16
Envista: $1.2 Billion Asset Impairments Was Fully Priced In
Summary Envista Holdings Corporation published Q2 2024 earnings results, highlighting a $1.2 billion non-cash charge from impairments. I find their valuation metrics quite attractive, comparing favorably to both the healthcare sector and their 5-year historical averages. Despite recent challenges, the company continues to generate positive free cash flows. Despite significant share price decline since 2022, insider buying activity by the CEO and CFO, attractive valuation ratios, and a 20% share price increase post-earnings led to a Buy rating. Read the full article on Seeking AlphaAnalysis Article • Aug 09
Why Investors Shouldn't Be Surprised By Envista Holdings Corporation's (NYSE:NVST) Low P/S
With a price-to-sales (or "P/S") ratio of 1.1x Envista Holdings Corporation ( NYSE:NVST ) may be sending bullish...Analysis Article • Jun 26
Envista Holdings (NYSE:NVST) Has A Somewhat Strained Balance Sheet
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Seeking Alpha • May 21
Envista Q1: Remain Hold Rated Given The Lack Of Positive Catalysts
Summary Envista's 1Q24 earnings showed weak organic revenue growth and declining margins, missing street expectations. The growth driver, Spark, experienced a sequential decline in growth, potentially due to pricing headwinds or slower conversion rates. The macro environment and competitive pressure continue to weigh on NVST's growth and margins, and the lack of guidance is concerning. Read the full article on Seeking AlphaAnalysis Article • May 04
Envista Holdings Corporation Just Missed Earnings - But Analysts Have Updated Their Models
Last week, you might have seen that Envista Holdings Corporation ( NYSE:NVST ) released its first-quarter result to the...Analysis Article • Apr 10
Is There An Opportunity With Envista Holdings Corporation's (NYSE:NVST) 40% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Envista Holdings fair value estimate is US$35.04 Current share...Analysis Article • Mar 06
Envista Holdings (NYSE:NVST) Seems To Use Debt Quite Sensibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Seeking Alpha • Feb 14
Envista Holdings: Rating Downgrade To Hold As Earnings Growth Is Going To Be Weak
Summary I downgraded my buy rating on Envista to a hold rating due to concerns about the company's ability to grow earnings. Envista reported a decline in core revenue and a decrease in margin performance, leading to disappointing earnings results. I believe that near-term margin performance will remain weak and that there are no visible catalysts to drive positive sentiment in the stock. Read the full article on Seeking AlphaShareholder Returns
| NVST | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -2.4% | -5.0% | 1.2% |
| 1Y | 22.5% | -23.5% | 27.0% |
Return vs Industry: NVST exceeded the US Medical Equipment industry which returned -21.8% over the past year.
Return vs Market: NVST underperformed the US Market which returned 28.2% over the past year.
Price Volatility
| NVST volatility | |
|---|---|
| NVST Average Weekly Movement | 5.5% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NVST has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: NVST's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 12,000 | Paul Keel | envistaco.com |
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products.
Envista Holdings Corporation Fundamentals Summary
| NVST fundamental statistics | |
|---|---|
| Market cap | US$3.80b |
| Earnings (TTM) | US$67.70m |
| Revenue (TTM) | US$2.81b |
55.1x
P/E Ratio1.3x
P/S RatioIs NVST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NVST income statement (TTM) | |
|---|---|
| Revenue | US$2.81b |
| Cost of Revenue | US$1.26b |
| Gross Profit | US$1.55b |
| Other Expenses | US$1.48b |
| Earnings | US$67.70m |
Last Reported Earnings
Apr 03, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.42 |
| Gross Margin | 55.25% |
| Net Profit Margin | 2.41% |
| Debt/Equity Ratio | 46.7% |
How did NVST perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/02 03:29 |
| End of Day Share Price | 2026/06/02 00:00 |
| Earnings | 2026/04/03 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Envista Holdings Corporation is covered by 21 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jeffrey Johnson | Baird |
| Glen Santangelo | Barclays |
| Allen Lutz | BofA Global Research |